US RE49,834 E1
Jak1 selective inhibitors and uses thereof
Congxin Liang, Palm Beach Gardens, FL (US)
Assigned to Hangzhou Highlightll Pharmaceutical Co., Ltd., Iselin, NJ (US)
Appl. No. 17/526,799
Filed by Hangzhou Highlightll Pharmaceutical Co., LTD, Hangzhou (CN)
PCT Filed Sep. 30, 2017, PCT No. PCT/US2017/054668
§ 371(c)(1), (2) Date Mar. 15, 2019,
PCT Pub. No. WO2018/067422, PCT Pub. Date Apr. 12, 2018.
Application 17/526,799 is a reissue of application No. 16/333,994, filed on Sep. 30, 2017, granted, now 10,738,060, issued on Aug. 11, 2020.
Claims priority of provisional application 62/403,660, filed on Oct. 3, 2016.
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 491/147 (2006.01); A61P 19/02 (2006.01); C07D 211/00 (2006.01)
CPC C07D 491/147 (2013.01) [A61P 19/02 (2018.01); C07D 211/00 (2013.01)] 22 Claims
 
[ 19. A compound of formula A1-14:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.]